Intravitreal sustained-release ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation.
(2002) In Acta Ophthalmologica Scandinavica 80(1). p.101-104- Abstract
- Purpose: To describe the treatment of cytomegalovirus (CMV) retinitis with intravitreal sustain-release ganciclovir devices in a 16-year-old patient in third remission of acute lymphoblastic leukemia after stem cell transplantation. METHODS: The patient received a stem cell transplant from an unrelated bone marrow donor after which he contracted a serious CMV infection manifested in the lungs and retinae. His immune system at this time was almost completely depleted. Implantation of a sustained-release ganciclovir device was performed in both eyes when retinitis progressed in spite of aggressive antiviral intravenous treatment. RESULTS: No per- or postoperative complications were noted. Infiltrates, hemorrhages and macular edema present... (More)
- Purpose: To describe the treatment of cytomegalovirus (CMV) retinitis with intravitreal sustain-release ganciclovir devices in a 16-year-old patient in third remission of acute lymphoblastic leukemia after stem cell transplantation. METHODS: The patient received a stem cell transplant from an unrelated bone marrow donor after which he contracted a serious CMV infection manifested in the lungs and retinae. His immune system at this time was almost completely depleted. Implantation of a sustained-release ganciclovir device was performed in both eyes when retinitis progressed in spite of aggressive antiviral intravenous treatment. RESULTS: No per- or postoperative complications were noted. Infiltrates, hemorrhages and macular edema present preoperatively dissolved over a period of six months. The final visual acuity was 1.0 in both eyes. The patients immune system and lung function slowly recovered during the same time period. CONCLUSIONS: The intravitreal ganciclovir implant provides safe and effective therapy against CMV retinitis, and should be considered in patients acquiring the infection after stem cell transplantation. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/105857
- author
- Ghosh, Fredrik LU ; Hansson, Lars-Jörgen ; Bynke, Gunnel LU and Békássy, Albert LU
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Acta Ophthalmologica Scandinavica
- volume
- 80
- issue
- 1
- pages
- 101 - 104
- publisher
- Wiley
- external identifiers
-
- pmid:11906315
- wos:000174388300021
- scopus:0036250164
- ISSN
- 1395-3907
- DOI
- 10.1034/j.1600-0420.2002.800121.x
- language
- English
- LU publication?
- yes
- id
- 4bb42d28-3e76-44d1-8138-9779994f72c0 (old id 105857)
- alternative location
- http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=11906315&dopt=Abstract
- date added to LUP
- 2016-04-01 16:19:46
- date last changed
- 2022-03-14 23:46:03
@article{4bb42d28-3e76-44d1-8138-9779994f72c0, abstract = {{Purpose: To describe the treatment of cytomegalovirus (CMV) retinitis with intravitreal sustain-release ganciclovir devices in a 16-year-old patient in third remission of acute lymphoblastic leukemia after stem cell transplantation. METHODS: The patient received a stem cell transplant from an unrelated bone marrow donor after which he contracted a serious CMV infection manifested in the lungs and retinae. His immune system at this time was almost completely depleted. Implantation of a sustained-release ganciclovir device was performed in both eyes when retinitis progressed in spite of aggressive antiviral intravenous treatment. RESULTS: No per- or postoperative complications were noted. Infiltrates, hemorrhages and macular edema present preoperatively dissolved over a period of six months. The final visual acuity was 1.0 in both eyes. The patients immune system and lung function slowly recovered during the same time period. CONCLUSIONS: The intravitreal ganciclovir implant provides safe and effective therapy against CMV retinitis, and should be considered in patients acquiring the infection after stem cell transplantation.}}, author = {{Ghosh, Fredrik and Hansson, Lars-Jörgen and Bynke, Gunnel and Békássy, Albert}}, issn = {{1395-3907}}, language = {{eng}}, number = {{1}}, pages = {{101--104}}, publisher = {{Wiley}}, series = {{Acta Ophthalmologica Scandinavica}}, title = {{Intravitreal sustained-release ganciclovir implants for severe bilateral cytomegalovirus retinitis after stem cell transplantation.}}, url = {{https://lup.lub.lu.se/search/files/4639414/623564.pdf}}, doi = {{10.1034/j.1600-0420.2002.800121.x}}, volume = {{80}}, year = {{2002}}, }